关注
Ting-Yuan Lan
Ting-Yuan Lan
Attending physician, NTUH Hsin-Chu branch
在 hch.gov.tw 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pregnancy outcomes in patients treated with belimumab: report from real-world experience
JH Kao, TY Lan, CH Lu, CF Cheng, YM Huang, CY Shen, SC Hsieh
Seminars in Arthritis and Rheumatism 51 (5), 963-968, 2021
222021
Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B
SC Huang, TH Su, TC Tseng, CL Chen, SJ Hsu, SH Liao, CM Hong, ...
Hepatology International 17 (5), 1139-1149, 2023
152023
Risk of Hepatitis B Virus (HBV) reactivation in HBsAg-negative, anti-HBc-negative patients receiving rituximab for autoimmune diseases in HBV endemic areas
TY Lan, YC Lin, TC Tseng, HC Yang, JH Kao, CF Cheng, TJ Lee, ...
Gut and Liver 17 (2), 288, 2023
112023
Monospecific anti-DFS70 antibodies are moderately helpful in excluding ANA-associated rheumatic disease in patients presenting with a dense fine speckled pattern-A systematic …
CF Cheng, TY Lan, MC Shih, KJ Li
Autoimmunity reviews 19 (10), 102637, 2020
112020
Metabolic dysfunction-associated steatotic liver disease facilitates hepatitis B surface antigen seroclearance and seroconversion
SC Huang, TH Su, TC Tseng, CL Chen, SJ Hsu, CH Liu, SH Liao, ...
Clinical Gastroenterology and Hepatology 22 (3), 581-590. e6, 2024
102024
Anti-DFS70 Antibodies for differentiating systemic autoimmune rheumatic disease in patients with positive ANA tests: a systematic review and meta-analysis
CF Cheng, MC Shih, TY Lan, KJ Li
Diagnostics 11 (9), 1592, 2021
102021
Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: a case report with literature review
TY Lan, YS Chen, CF Cheng, ST Huang, CY Shen, PN Hsu
Lupus 30 (11), 1849-1855, 2021
62021
Characteristics and potential risk factors of hydroxychloroquine retinopathy in patients with systemic lupus erythematosus: Focusing on Asian population
JH Kao, TT Lai, CH Lu, TY Lan, YT Hsieh, CY Shen, KJ Li, SC Hsieh
Journal of Ocular Pharmacology and Therapeutics 38 (10), 728-733, 2022
52022
Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics
WD Liu, SY Chang, TY Lan, YC Lin, JH Kao, CH Liao, MJ Tsai, PH Kuo, ...
Journal of the Formosan Medical Association 120 (5), 1269-1273, 2021
42021
More Steps Forward to Optimize the Dosing of Hydroxychloroquine: Comment on the Article by Petri et al.
JH Kao, TY Lan, KJ Li
Arthritis & Rheumatology (Hoboken, NJ) 73 (11), 2149-2149, 2021
12021
Risk of rituximab-induced hepatitis B flare after antiviral discontinuation in rheumatic patients with chronic hepatitis B virus.
TY Lan, TW Chang, TC Tseng, TJ Lee, JH Kao, CF Cheng, SC Huang, ...
Clinical and Experimental Rheumatology, 2024
2024
AB1099 RENAL FUNCTION TRAJECTORIES IN LUPUS NEPHRITIS PATIENTS RECEIVING IMMUNOSUPPRESSIVE OR B CELL-DEPLETING THERAPY
TJ Lee, TY Lan, TW Chang, CH Lu, SC Hsieh
Annals of the Rheumatic Diseases 83 (Suppl 1), 1878-1879, 2024
2024
AB1393 HYDROXYCHLOROQUINE (HCQ) BLOOD LEVEL AS AN ADDITIONAL RISK FACTOR IN PATIENTS WITH A HIGH RISK OF DEVELOPING HCQ RETINOPATHY IN THE ASIAN POPULATION: A CASE-CONTROL …
TW Chang, TT Lai, GY Chen, TY Lan, JH Kao, TJ Lee, KY Lin, SC Hsieh, ...
Annals of the Rheumatic Diseases 83 (Suppl 1), 2050-2051, 2024
2024
Correspondence Address correspondence to: Tung-Hung Su, MD, PhD,. e-mail: tunghungsu@ ntu. edu. tw; fax: 886-2-23825962; or Jia-Horng Kao, MD, PhD, FAASLD,. e-mail: kaojh@ ntuh …
SC Huang, TH Su, TC Tseng, CL Chen, SJ Hsu, CH Liu, SH Liao, ...
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 22 (3), 2024
2024
PRE-EXISTING AND NEWLY-DEVELOPED METABOLIC DYSFUNCTIONS INCREASE THE RISKS OF CIRRHOSIS AND ITS COMPLICATIONS IN CHRONIC HEPATITIS B PATIENTS
SC Huang, TH Su, TC Tseng, CL Chen, SJ Hsu, CH Liu, SH Liao, ...
HEPATOLOGY 78, S482-S483, 2023
2023
The significance of dense fine speckled pattern in antinuclear antibody‐associated rheumatic disease and coexisting autoantibodies: A propensity score‐matched cohort study
CF Cheng, TY Lan, JH Kao, CH Lu, YC Chang, YM Huang, FJ Yang, ...
International Journal of Rheumatic Diseases 26 (9), 1667-1675, 2023
2023
Clinical utility of myositis antibody clustering by line-blot assay in patients with myositis-spectrum disorders
TJ Lee, TY Lan, CA Chuang, KY Lin, SC Hsieh
Formosan Journal of Rheumatology 36 (2), 18-24, 2022
2022
Association of myositis-specific antibodies in patients with idiopathic inflammatory myopathies and malignancies
CA Chuang, TY Lan, TJ Lee, KY Lin, SC Hsieh
Formosan Journal of Rheumatology 36 (2), 80-87, 2022
2022
10-year-survival rate and specific cause of death in patients with systemic lupus erythematosus: a single center retrospective study
KY Lin, TY Lan, TJ Lee, CA Chuang, SC Hsieh
Formosan Journal of Rheumatology 36 (2), 70-79, 2022
2022
Pre-existing and new-onset metabolic dysfunctions increase cirrhosis and its complication risks in chronic hepatitis B
SC Huang, TH Su, TC Tseng, SH Liao, SJ Hsu, CM Hong, TY Lan, CH Liu, ...
Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20